Studies in Taiwanese cohorts using this technology showed significant increases in Aβ42 and tau concentrations in plasma samples of subjects with mild cognitive impairment (MCIs) due to AD, and in early-stage AD (Chiu et al., 2012). Here, MAPT is linked to Alzheimer disease.